MB "NorthSpeed Biotech" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
37,543 |
- |
5,984 |
5,984 |
- |
25.09 |
15.94 |
6,983 |
1,614 |
0 |
8,597 |
2023 |
---|
214,769 |
- |
32,672 |
31,038 |
- |
18.77 |
14.45 |
38,021 |
16,594 |
5,000 |
49,615 |
2024 |
---|
331,392 |
- |
68,091 |
59,168 |
- |
29.21 |
17.85 |
59,947 |
18,114 |
8,835 |
69,226 |
Register and
explore Okredo data2024 |
---|
331,392 |
- |
68,091 |
59,168 |
- |
29.21 |
17.85 |
59,947 |
18,114 |
8,835 |
69,226 |
Register and
explore Okredo data2024
Turnover (€)
331,392 €54 % *
Sales per employee (€)
-Profit before tax (€)
68,091 €108 % *
Net Profit (€)
59,168 €91 % *
Profit per employee (€)
-Total profitability (%)
29.21 %55.62 % *
Net profitability (%)
17.85 %23.53 % *
Equity (€)
59,947 €58 % *
Amounts Payable And Liabilities (€)
18,114 €9 % *
Non-current Assets (€)
8,835 €77 % *
CurrentAssets (€)
69,226 €40 % *